BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19615280)

  • 1. [Detection and identification of specific serum biomarkers in papillary thyroid cancer].
    Wang JX; Dong R; Liu QL; Yang SB; Fan YX; Zhang Q; Yang FQ; Wu P; Yu JK; Zheng S
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):265-8. PubMed ID: 19615280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Screening and identification analysis of serum protein biomarkers in nephroblastoma].
    Wang JX; Yang SB; Liu QL; Dong R; Fan YX; Zhang Q; Yang FQ; Wu P; Yu JK; Zheng S
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1259-63. PubMed ID: 19595180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and identification of potential biomarkers of papillary thyroid carcinoma.
    Fan Y; Shi L; Liu Q; Dong R; Zhang Q; Yang S; Fan Y; Yang H; Wu P; Yu J; Zheng S; Yang F; Wang J
    Mol Cancer; 2009 Sep; 8():79. PubMed ID: 19785722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of serum protein fingerprint in diagnosis of papillary thyroid carcinoma.
    Wang JX; Yu JK; Wang L; Liu QL; Zhang J; Zheng S
    Proteomics; 2006 Oct; 6(19):5344-9. PubMed ID: 16941571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
    Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
    BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of serum protein fingerprint model and support vector machine in diagnosis of thyroid cancer].
    Wang JX; Wang L; Fan YZ; Liu QL; Zhang J; Yu JK; Zheng S
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):979-82. PubMed ID: 16759540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum proteomic patterns may assist the diagnosis of solitary pulmonary nodules].
    Luo XY; Chen HQ; Sun YH; Zhou JH; Wang WF; Liao P; Xiang CQ
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):907-10. PubMed ID: 17533741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of papillary thyroid carcinoma with serum protein profile analysis.
    Moretz WH; Gourin CG; Terris DJ; Xia ZS; Liu Z; Weinberger PM; Chin E; Adam BL
    Arch Otolaryngol Head Neck Surg; 2008 Feb; 134(2):198-202. PubMed ID: 18283164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot study using SELDI-TOF-MS based proteomic profile for the identification of diagnostic biomarkers of thyroid proliferative diseases.
    Suriano R; Lin Y; Ashok BT; Schaefer SD; Schantz SP; Geliebter J; Tiwari RK
    J Proteome Res; 2006 Apr; 5(4):856-61. PubMed ID: 16602693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
    Geng X; Wang F; Li YG; Zhu GP; Zhang WM
    J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proteinchip-flight mass spectrometry for screening differentially expressed proteins in the serum of cervical cancer patients].
    Cai SN; Liu GB; Guo XH; Chen JG; Zhang J; Wu YL; Liang WJ; Luo RC
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):32-5. PubMed ID: 19218106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
    Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
    Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Identification of colorectal cancer using proteomic patterns in serum].
    Zhao G; Gao CF; Song GY; Li DH; Wang XL
    Ai Zheng; 2004 Jun; 23(6):614-8. PubMed ID: 15191657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted serum glycoproteomics for the discovery of lung cancer-associated glycosylation disorders using lectin-coupled ProteinChip arrays.
    Ueda K; Fukase Y; Katagiri T; Ishikawa N; Irie S; Sato TA; Ito H; Nakayama H; Miyagi Y; Tsuchiya E; Kohno N; Shiwa M; Nakamura Y; Daigo Y
    Proteomics; 2009 Apr; 9(8):2182-92. PubMed ID: 19322776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
    Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P
    Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
    Zhang GQ; Du J; Pang D
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
    Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
    Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening of differentially expressed proteins associated with directional highly lymphatic metastasis in ovarian carcinoma cell lines using SELDI-TOF-MS technology].
    Guan X; Li DR; Wang Q; Li L; Ruan HY; Zhang W
    Ai Zheng; 2008 Nov; 27(11):1155-60. PubMed ID: 19000445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.